Catching cancer's earliest moments: How mutated cells transform their local environment so a tumor can develop

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...

Liver cancer roadmap links tumor hallmarks to treatment, including targetable mutations

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...
The American Journal of Managed Care

Advances in Ovarian Cancer: Using Genomics and Optimizing Maintenance Therapy

Ovarian cancer management is challenging due to high morbidity and mortality, often from late-stage diagnoses. Advances in tumor genomics have led to targeted therapies, improving outcomes for ...
ascopubs.org

Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From ...
CURE

Rezatapopt Shows Activity in Pretreated Ovarian Cancer With TP53 Mutation

Rezatapopt is a first-in-class oral therapy designed to target the TP53 Y220C mutation. This mutation affects the p53 protein ...
EurekAlert!

Malignancies of ISCs and their niche emerge as frontiers in precision therapy for colorectal cancer

A new study reveals that malignant transformation of intestinal stem cells (ISCs) and their supportive microenvironment ...
Healio

Low-dose aspirin reduces colorectal cancer recurrence for patients with PI3K mutations

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...
The Conversation

Comment débutent les cancers du sein ? Conversation avec la biochimiste Alexandra Van Keymeulen

Alexandra Van Keymeulen est biochimiste et spécialiste du cancer du sein. Avec son équipe, elle explore les étapes extrêmement précoces dans le développement des tumeurs, bien avant que celles-ci ne ...